We performed universal reverse transcription (RT) using SuperScript II according to the manufacturer's recommendations. Briefly, 1.5 µM oligo-dT15, 1.5 µM random hexamers, 0.5 mM dNTPs (all Sigma-Aldrich) and 100 pg total RNA were incubated in 6.5 µL at 65°C for 5 min and then chilled to 4°C. Next, 1x first-strand buffer, 10 mM DTT, 30 U RNaseOUT, and 38 U SuperScript II enzyme (all Thermo Fisher Scientific) were added to a final volume of 15 µL. Final RT concentrations are shown. RT was performed at 25°C for 10 min, 42°C for 90 min, and 70°C for 15 min. cDNA was stored at -20°C.
First, the mRNA poly-A tail is primed with a primer containing both an oligo-dT sequence (blue) and an adapter sequence (red). Reverse transcriptase generates full-length cDNA (grey) and adds 3-5 extra residues of cytosine (green) at the 3' cDNA end. With the help of a template switching oligonucleotide (red) containing three guanine residues (green), reverse transcriptase can synthesise an adapter sequence attached to the 3' cDNA end (full-length reverse transcription). A single adapter primer is used to preamplify the whole transcriptome (adapter-based preamplification). (b) In target-specific preamplification, a blend of random hexamers (grey) and oligo-dT (blue) primes total RNA, generating cDNA (grey) (universal reverse transcription). A pool of all target primers is used to preamplify the sequences of interest (multiplex preamplification). all relative copy numbers have been divided by 9.3 and resulting values < 1 were removed to mimic the reduced yield obtained by global preamplification. Similar PCA is also generated with even higher cut-off (data not shown). Data points represent individual astrocytes derived from mouse brains before (day 0, black), and after (day 3, blue, day 7, lime, and day 14, red) ischemia. 
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